News from the Norwegian Institute of Public Health
More news
-
Children exposed to many environmental contaminants
Published
-
Stoltenberg and Ottersen members in new Lancet Commission
Published
-
Decrease in new type 2 diabetes cases in Norway
Published
-
Meningococcal disease: Short way from harmless bacteria to major epidemics
Published
-
76,000 elderly people were dispensed at least 15 medicines during 2017
Published
-
NIPH to lead European adolescent obesity project
Published
-
40 per cent increase in drug costs over four years
Published
What’s new
-
Research overview
Effects of partial sick leave versus full-time sick leave on sickness absence and work participation
The Norwegian Labor and Welfare Administration (NAV) commissioned us to map all evidence on the effects of PTSL versus full-time sick leave (FTSL) on sickness absence and work participation.
Published
-
Report
Health in Norway – 2017: Commentary report for OECD comparison of health in different countries
«Health at a Glance» is a series of reports published by the OECD every other year. They present the most recent comparable data on health status of populations and health systems in OECD countries.
Updated
-
Report
Interlaboratory Comparison on POPs in Food 2018
The 19th round of the interlaboratory comparison study on the determination of PCDDs/PCDFs, PCBs and brominated flame retardants in three food items were conducted in spring of 2018.
Published
-
Systematic review
Tapering from buprenorphine or methadone for pregnant women in opioid maintenance treatment (OMT)
We have summarised the evidence on effects for mother and child of tapering compared with continued maintenance treatment during pregnancy.
Published
-
Report
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017
The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for a number of viruses.
Published
-
Note
National plan of action to sustain a poliomyelitis-free status
The plan has been developed so that Norway is prepared for a possible renewed outbreak of wild poliovirus (WPV) or vaccine derived polio virus (VDPV).
Published